home / stock / opti:cc / opti:cc news

OPTI:CC News and Press, Optimi Health Corp.

Stock Information
Company Name: Optimi Health Corp.
Stock Symbol: OPTI:CC
Market: CNQC
Website: optimihealth.ca
Menu
OPTI:CC OPTI:CC Quote OPTI:CC Short OPTI:CC News OPTI:CC Articles OPTI:CC Message Board
Get OPTI:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
OPTI:CC - Optimi Health to Enter Asian Market with PsiloThai Collaboration on Psilocybin Research

Observational studies to focus on patients with addiction and end-of-life distress pending formal approval and permitting from Thai health authorities Vancouver, British Columbia--(Newsfile Corp. - July 23, 2024) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) (" Optimi " or the " Co...
OPTI:CC - Optimi Health and Mind Medicine Australia Launch OptiMed Prescriber Portal for Australian Psychiatrists

Vancouver, British Columbia--(Newsfile Corp. - June 27, 2024) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) (" Optimi " or the " Company "), a Health Canada-approved, GMP-compliant pharmaceutical drug manufacturer specializing in the controlled substances MDMA and botanical psilocyb...

OPTI:CC - Health Canada Issues Three Export Permits to Optimi to Supply Patients Under Australia's Authorised Prescriber Scheme

The Company will ship 160 doses of MDMA and psilocybin to Australian psychiatrists for the treatment of patients with PTSD and Treatment-Resistant Depression. Vancouver, British Columbia--(Newsfile Corp. - June 25, 2024) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ( "Optimi" o...

OPTI:CC - Optimi Health Completes First International Shipment of MDMA to Israel and Secures CBSA Exporters Authorization ID

Vancouver, British Columbia--(Newsfile Corp. - June 11, 2024) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) (" Optimi " or the " Company "), a leading Health Canada licensed GMP psychedelics pharmaceutical manufacturer, specializing in controlled substances such as botanical psilocy...
OPTI:CC - Canadian Investment Regulatory Organization Trade Resumption - OPTI

Canadian Investment Regulatory Organization Trade Resumption - OPTI Canada NewsWire VANCOUVER, BC , June 3, 2024 /CNW/ - Trading resumes in: Company: Optimi Health Corp. CSE Symbol: OPTI All Issues: Yes Resumption (ET): 12:15 PM CIRO can make ...

OPTI:CC - Optimi Health Awarded Drug Establishment Licence From Health Canada

Optimi Health Awarded Drug Establishment Licence From Health Canada Canada NewsWire VANCOUVER, BC , June 3, 2024 /CNW/ - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) ( "Optimi" or the "Company" ), a leading Health Canada-licensed psychede...

OPTI:CC - Canadian Investment Regulatory Organization Trading Halt - OPTI

Canadian Investment Regulatory Organization Trading Halt - OPTI Canada NewsWire VANCOUVER, BC , June 3, 2024 /CNW/ - The following issues have been halted by CIRO: Company: Optimi Health Corp. CSE Symbol: OPTI All Issues: Yes Reason: Pending News ...
OPTI:CC - Optimi Health Announces Closing of Fully Subscribed $1,500,000 Financing

Optimi Health Announces Closing of Fully Subscribed $1,500,000 Financing Canada NewsWire VANCOUVER, BC , May 31, 2024 /CNW/ - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Health Canada-licensed GMP psychedelics pharmaceutical manufact...

OPTI:CC - Optimi Health Secures Import Permit from Mind Medicine Australia for MDMA and Psilocybin Capsules

VANCOUVER, British Columbia, May 29, 2024 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Health Canada licensed GMP psychedelics pharmaceutical manufacturer, specializing in controlled substances such as psilocybin and MDMA, is pleased to announce tha...

OPTI:CC - Optimi Health, ATMA Sign Letter of Intent To Advance Phase II Clinical Trial Group and Individual Administration Protocol For Major Depressive Disorder

VANCOUVER, British Columbia, May 22, 2024 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Health Canada licensed psychedelics pharmaceutical manufacturer, specializing in controlled substances such as botanical psilocybin and MDMA, has entered a Letter...
Next 10